Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	December 31,
	2023		2022
Accrued payments due to AstraZeneca	$	3,680	$	3,385
Accrued gross to net revenue liabilities	3,258		1,991
Accrued contract manufacturing expenses	1,946		1,657
Accrued sales and marketing expenses	3,223		587
Accrued professional and consulting services	486		808
Derivative liability for exit fees	675		1,656
Accrued clinical expenses	377		223
Accrued non-clinical research and development expenses	30		1,188
Other	1,366		885
Total accrued expenses and other current liabilities	$	15,041	$	12,380